Class I
Drug Recall: Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
AvKARE · March 28, 2024
Reason for Recall
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Distribution
US Nationwide.
States Affected
NATIONWIDE
Quantity Affected
153 cartons
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0444-2024
Status: terminated
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.